Can a mother who has taken a steroid (corticosteroid) still breastfeed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Mother Who Took a Steroid Still Breastfeed?

Yes, a mother who has taken corticosteroids can and should continue breastfeeding—corticosteroids are found in only low concentrations in breast milk and pose minimal risk to the nursing infant. 1

Evidence-Based Safety Profile

Corticosteroids transfer into breast milk in minimal amounts that are too small to cause pharmacological effects in the infant. 2 The available data across multiple medical specialties consistently demonstrate that:

  • Systemic corticosteroids appear in human milk but at concentrations that do not warrant discontinuation of breastfeeding 1
  • Glucocorticoids are excreted minimally into breast milk, and breastfeeding by women on low-dose corticosteroid therapy is generally considered safe with low risk of adverse effects on nursing infants 2
  • The use of prednisolone (a commonly used corticosteroid) is considered safe during lactation 1

Clinical Recommendations

Continue breastfeeding without interruption when using corticosteroids at typical therapeutic doses. 1, 2 The decision to breastfeed should be made independent of corticosteroid therapy, considering the advantages to the newborn and the benefits to the mother. 1

Timing Considerations

The evidence on timing breastfeeding around medication administration is mixed:

  • The 2016 Toronto Consensus (Gastroenterology) explicitly rejected the need to avoid breastfeeding within 4 hours of corticosteroid administration, concluding there was little evidence to support discarding breast milk or timing feeds around medication intake 1
  • However, for mothers using high-dose corticosteroids (≥20 mg daily prednisone equivalent), the 2020 American College of Rheumatology guideline suggests discarding breast milk obtained within 4 hours following medication to minimize infant exposure 1
  • For prednisolone specifically, infant exposure can be further minimized by avoiding breastfeeding during the first 4 hours after medication intake when equilibrium between breast milk and maternal serum occurs—a strategy that may be applied to other corticosteroids if additional caution is desired 2

Dose-Specific Guidance

For low-dose corticosteroids (<20 mg prednisone daily or equivalent):

  • Continue breastfeeding without any timing restrictions 1
  • No need to discard breast milk 1

For high-dose corticosteroids (≥20 mg prednisone daily or equivalent):

  • Continue breastfeeding but consider discarding breast milk obtained within 4 hours of medication administration 1
  • Alternatively, time breastfeeding sessions to occur more than 4 hours after medication intake if feasible 2

Important Caveats

Fluorinated vs. Non-Fluorinated Steroids

  • Prednisone or non-fluorinated steroid equivalents are preferred during breastfeeding 1
  • Dexamethasone (a fluorinated steroid) transfers minimally into breast milk and breastfeeding can continue without interruption, though it is not the first-line choice 2

Disease Control Priority

Maintaining maternal disease control takes priority—discontinuing corticosteroids postpartum may lead to disease flare, which poses greater risk to both mother and infant than the minimal drug exposure through breast milk. 1 Postpartum discontinuation of medication can trigger disease relapse, and untreated maternal disease carries its own risks. 1

Benefits of Breastfeeding

The benefits of breastfeeding consistently outweigh the minimal theoretical risks from corticosteroid exposure:

  • Breastfeeding has not been associated with increased risk of maternal disease flare and may actually be protective against relapse 1
  • Breastfeeding may have a protective effect against development of early-onset inflammatory conditions in offspring 1

Common Pitfalls to Avoid

  • Do not advise mothers to discontinue breastfeeding based solely on corticosteroid use—this is the most common error and deprives infants of breastfeeding benefits unnecessarily 3, 4
  • Do not confuse systemic corticosteroids with topical/intranasal formulations—intranasal corticosteroids like fluticasone have even more minimal systemic absorption and are definitively safe during breastfeeding 5
  • Avoid switching to less effective medications out of unfounded concern—the risk of undertreated maternal disease exceeds the minimal risk from corticosteroid exposure in breast milk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dexamethasone Safety in Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Research

Medications in pregnancy and lactation.

Emergency medicine clinics of North America, 2003

Guideline

Fluticasone Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is it safe to take Adderall (amphetamine and dextroamphetamine) while breastfeeding?
Is sacubitril-valsartan (Entresto), dapagliflozin (Forxiga), and eplerenone (Inspra) safe during breastfeeding?
Is ceftaroline (Ceftaroline fosamil) safe for use in breastfeeding mothers?
Is it safe to breastfeed while taking Vyvanse (lisdexamfetamine)?
What type of medication is preferred for use during breastfeeding to reduce the risk of harm to the infant, considering characteristics such as oral bioavailability and protein binding?
What is the best course of management for a 24-year-old postpartum (after childbirth) female, 11 weeks after delivery, presenting with low-grade fever, nausea, and abdominal pain, with signs of mastitis (inflammation of breast tissue) and CT scan results showing inflammatory-appearing thickening of the distal ileum and right transverse hemicolon?
What are the potential complications of a total thyroidectomy in an adult patient with a history of thyroid disease, such as thyroid cancer or hyperthyroidism?
What are the considerations and recommendations for a patient undergoing an awake facelift under local anesthesia or sedation, particularly in terms of patient selection, pre-operative evaluation, and post-operative care?
What does Mean Corpuscular Hemoglobin (MCH) indicate in a patient with anemia or other blood disorders?
How can I rely on future control exam results with a chronically colonized JJ (double J) stent and a history of cancer if the urinary tract infection cannot be fully eradicated?
How can healthcare providers address medical trauma that feels like assault and betrayal in patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.